Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Development

Phase 3 Trials

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

The split votes highlight regulators' push for proof that early treatment changes extend lives.

EMA Validates Astellas Bid to Add Padcev–Keytruda Combo for Perioperative Muscle-Invasive Bladder Cancer

Kailera Leaps 62% in Nasdaq Debut After $625 Million IPO

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

J&J Myeloma Trial Stopped Early After Tecvayli–Darzalex Shows PFS and OS Benefit

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials